Unique features of TRIM5α among closely related human TRIM family members

Virology

Volumn 360, Issue 2, 2007, Pages 419-433

  Li, Xing ^a   Gold, Bert ^b   O'hUigin, Colm ^c   Diaz Griffero, Felipe ^a   Song, Byeongwoon ^a   Si, Zhihai ^a   Li, Yuan ^a   Yuan, Wen ^a   Stremlau, Matthew ^a   Mische, Claudia ^a   Javanbakht, Hassan ^a   Scally, Mark ^b   Winkler, Cheryl ^c   Dean, Michael ^b   Sodroski, Joseph ^a,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c SAIC FREDERICK INC   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

B30.2(SPRY) domain; Capsid binding; Nonsynonymous synonymous; Positive selection; RBCC; Restriction factor; Retrovirus; RING; Tripartite motif

Indexed keywords

ANTIVIRUS AGENT; SPROUTY PROTEIN; TRIPARTITE MOTIF PROTEIN 21; TRIPARTITE MOTIF PROTEIN 22; TRIPARTITE MOTIF PROTEIN 27; TRIPARTITE MOTIF PROTEIN 34; TRIPARTITE MOTIF PROTEIN 4; TRIPARTITE MOTIF PROTEIN 5; TRIPARTITE MOTIF PROTEIN 6; UNCLASSIFIED DRUG; CARRIER PROTEIN; MEMBRANE PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TRIM PROTEIN, HUMAN; TRIM34 PROTEIN, HUMAN; TRIM5 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; CYTOPLASM; EMBRYO; GENE OVEREXPRESSION; GENETIC SELECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MONKEY DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN METABOLISM; PROTEIN MOTIF; RETROVIRUS INFECTION; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS CAPSID; VIRUS INHIBITION; VIRUS NUCLEOCAPSID; ANIMAL; CELL LINE; CHEMISTRY; DOG; GENETICS; HELA CELL; IMMUNOLOGY; MACACA; METABOLISM; PHYLOGENY; PHYSIOLOGY; PROTEIN BINDING;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MIRIDAE; SIMIAN IMMUNODEFICIENCY VIRUS;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CARRIER PROTEINS; CELL LINE; CYTOPLASM; DOGS; HELA CELLS; HIV-1; HUMANS; MACACA MULATTA; MEMBRANE PROTEINS; NUCLEOCAPSID; PHYLOGENY; PROTEIN BINDING;

EID: 33947722206     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.10.035     Document Type: Article

References (61)

1. Asaoka K., Ikeda K., Hishinuma T., Horie-Inoue K., Takeda S., and Inoue S. A retrovirus restriction factor TRIM5alpha is transcriptionally regulated by interferons. Biochem. Biophys. Res. Commun. 338 4 (2005) 1950-1956
2. Besnier C., Takeuchi Y., and Towers G. Restriction of lentivirus in monkeys. Proc. Natl. Acad. Sci. U.S.A. 99 18 (2002) 11920-11925
3. Bieniasz P.D. Restriction factors: a defense against retroviral infection. Trends Microbiol. 11 6 (2003) 286-291
4. Chelbi-Alix M.K., Pelicano L., Quignon F., Koken M.H., Venturini L., Stadler M., Pavlovic J., Degos L., and de The H. Induction of the PML protein by interferons in normal and APL cells. Leukemia 9 12 (1995) 2027-2033
5. Chelbi-Alix M.K., Quignon F., Pelicano L., Koken M.H., and de The H. Resistance to virus infection conferred by the interferon-induced promyelocytic leukemia protein. J. Virol. 72 2 (1998) 1043-1051
6. Cowan S., Hatziioannou T., Cunningham T., Muesing M.A., Gottlinger H.G., and Bieniasz P.D. Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism. Proc. Natl. Acad. Sci. U.S.A. 99 18 (2002) 11914-11919
7. Diaz-Griffero F., Li X., Javanbakht H., Song B., Welikala S., Stremlau M., and Sodroski J. Rapid turnover and polyubiquitylation of the retroviral restriction factor TRIM5. Virology 349 2 (2006) 300-315
8. Diaz-Griffero F., Vandegraaff N., Li Y., McGee-Estrada K., Stremlau M., Welikala S., Si Z., Engelman A., and Sodroski J. Requirements for capsid-binding and an effector function in TRIMCyp-mediated restriction of HIV-1. Virology 351 2 (2006) 404-419
9. Everett R.D., Rechter S., Papior P., Tavalai N., Stamminger T., and Orr A. PML contributes to a cellular mechanism of repression of herpes simplex virus type 1 infection that is inactivated by ICP0. J. Virol. 80 (2006) 7995-8005
10. Fridell R.A., Harding L.S., Bogerd H.P., and Cullen B.R. Identification of a novel human zinc finger protein that specifically interacts with the activation domain of lentiviral Tat proteins. Virology 209 2 (1995) 347-357
11. Ganser B.K., Li S., Klishko V.Y., Finch J.T., and Sundquist W.I. Assembly and analysis of conical models for the HIV-1 core. Science 283 5398 (1999) 80-83
12. Gascuel O. BIONJ: an improved version of the NJ algorithm based on a simple model of sequence data. Mol. Biol. Evol. 14 7 (1997) 685-695
13. Gongora C., Tissot C., Cerdan C., and Mechti N. The interferon-inducible Staf50 gene is downregulated during T cell costimulation by CD2 and CD28. J. Interferon Cytokine Res. 20 11 (2000) 955-961
14. Haldane J.B.S. Disease and evolution. Ric. Sci., Suppl. A19 (1949) 68-76
15. Hancock J.M. Gene factories, microfunctionalization and the evolution of gene families. Trends Genet. 21 11 (2005) 591-595
16. Hatziioannou T., Cowan S., Goff S.P., Bieniasz P.D., and Towers G.J. Restriction of multiple divergent retroviruses by Lv1 and Ref1. EMBO J. 22 3 (2003) 385-394
17. Hatziioannou T., Cowan S., Von Schwedler U.K., Sundquist W.I., and Bieniasz P.D. Species-specific tropism determinants in the human immunodeficiency virus type 1 capsid. J. Virol. 78 11 (2004) 6005-6012
18. Hatziioannou T., Perez-Caballero D., Yang A., Cowan S., and Bieniasz P.D. Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha. Proc. Natl. Acad. Sci. U.S.A. 101 29 (2004) 10774-10779
19. Himathongkham S., and Luciw P.A. Restriction of HIV-1 (subtype B) replication at the entry step in rhesus macaque cells. Virology 219 2 (1996) 485-488
20. Hofmann W., Schubert D., LaBonte J., Munson L., Gibson S., Scammell J., Ferrigno P., and Sodroski J. Species-specific, postentry barriers to primate immunodeficiency virus infection. J. Virol. 73 12 (1999) 10020-10028
21. Javanbakht H., Diaz-Griffero F., Stremlau M., Si Z., and Sodroski J. The contribution of RING and B-box 2 domains to retroviral restriction mediated by monkey TRIM5alpha. J. Biol. Chem. 280 29 (2005) 26933-26940
22. Javanbakht H., Yuan W., Yeung D.F., Song B., Diaz-Griffero F., Li Y., Li X., Stremlau M., and Sodroski J. Characterization of TRIM5alpha trimerization and its contribution to human immunodeficiency virus capsid binding. Virology 353 1 (2006) 234-246
23. Jensen K., Shiels C., and Freemont P.S. PML protein isoforms and the RBCC/TRIM motif. Oncogene 20 49 (2001) 7223-7233
24. Katoh K., Kuma K., Toh H., and Miyata T. MAFFT version 5: improvement in accuracy of multiple sequence alignment. Nucleic Acids Res. 33 2 (2005) 511-518
25. Keckesova Z., Ylinen L.M., and Towers G.J. The human and African green monkey TRIM5alpha genes encode Ref1 and Lv1 retroviral restriction factor activities. Proc Natal Acad Sci U S A 101 29 (2004) 10780-10785
26. Kootstra N.A., Munk C., Tonnu N., Landau N.R., and Verma I.M. Abrogation of postentry restriction of HIV-1-based lentiviral vector transduction in simian cells. Proc. Natl. Acad. Sci. U.S.A. 100 3 (2003) 1298-1303
27. Li W.H. Unbiased estimation of the rates of synonymous and nonsynonymous substitution. J. Mol. Evol. 36 1 (1993) 96-99
28. Li S., Hill C.P., Sundquist W.I., and Finch J.T. Image reconstructions of helical assemblies of the HIV-1 CA protein. Nature 407 6802 (2000) 409-413
29. Li X., Li Y., Stremlau M., Yuan W., Song B., Perron M., and Sodroski J. Functional replacement of the RING, B-box 2, and coiled-coil domains of tripartite motif 5alpha (TRIM5alpha) by heterologous TRIM domains. J. Virol. 80 13 (2006) 6198-6206
30. Li Y., Li X., Stremlau M., Lee M., and Sodroski J. Removal of arginine 332 allows human TRIM5α to bind human immunodeficiency virus (HIV-1) capsids and to restrict infection. J. Virol. 80 (2006) 6738-6744
31. Liu H.L., Wang Y.Q., Liao C.H., Kuang Y.Q., Zheng Y.T., and Su B. Adaptive evolution of primate TRIM5alpha, a gene restricting HIV-1 infection. Gene 362 (2005) 109-116
32. Mische C.C., Javanbakht H., Song B., Diaz-Griffero F., Stremlau M., Strack B., Si Z., and Sodroski J. Retroviral restriction factor TRIM5alpha is a trimer. J. Virol. 79 22 (2005) 14446-14450
33. Nisole S., Lynch C., Stoye J.P., and Yap M.W. A trim5-cyclophilin A fusion protein found in owl monkey kidney cells can restrict HIV-1. Proc. Natal. Acad. Sci. U.S.A. 101 (2004) 13318-13324
34. Nisole S., Stoye J.P., and Saib A. TRIM family proteins: retroviral restriction and antiviral defence. Nat. Rev., Microbiol. 3 10 (2005) 799-808
35. Orimo A., Tominaga N., Yoshimura K., Yamauchi Y., Nomura M., Sato M., Nogi Y., Suzuki M., Suzuki H., Ikeda K., Inoue S., and Muramatsu M. Molecular cloning of ring finger protein 21 (RNF21)/interferon-responsive finger protein (ifp1), which possesses two RING-B box-coiled coil domains in tandem. Genomics 69 1 (2000) 143-149
36. Owens C.M., Yang P.C., Gottlinger H., and Sodroski J. Human and simian immunodeficiency virus capsid proteins are major viral determinants of early, postentry replication blocks in simian cells. J. Virol. 77 1 (2003) 726-731
37. Owens C.M., Song B., Perron M.J., Yang P.C., Stremlau M., and Sodroski J. Binding and susceptibility to postentry restriction factors in monkey cells are specified by distinct regions of the human immunodeficiency virus type 1 capsid. J. Virol. 78 10 (2004) 5423-5437
38. Perez-Caballero D., Hatziioannou T., Zhang F., Cowan S., and Bieniasz P.D. Restriction of human immunodeficiency virus type 1 by TRIM-CypA occurs with rapid kinetics and independently of cytoplasmic bodies, ubiquitin, and proteasome activity. J. Virol. 79 24 (2005) 15567-15572
39. Perron M.J., Stremlau M., Song B., Ulm W., Mulligan R.C., and Sodroski J. TRIM5alpha mediates the postentry block to N-tropic murine leukemia viruses in human cells. Proc. Natl. Acad. Sci. U.S.A. 101 32 (2004) 11827-11832
40. Reymond A., Meroni G., Fantozzi A., Merla G., Cairo S., Luzi L., Riganelli D., Zanaria E., Messali S., Cainarca S., Guffanti A., Minucci S., Pelicci P.G., and Ballabio A. The tripartite motif family identifies cell compartments. EMBO J. 20 9 (2001) 2140-2151
41. Saurin A.J., Borden K.L., Boddy M.N., and Freemont P.S. Does this have a familiar RING?. Trends Biochem. Sci. 21 6 (1996) 208-214
42. Sawyer S.L., Emerman M., and Malik H.S. Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G. PLoS Biol. 2 9 (2004) E275
43. Sawyer S.L., Wu L.I., Emerman M., and Malik H.S. Positive selection of primate TRIM5alpha identifies a critical species-specific retroviral restriction domain. Proc. Natl. Acad. Sci. U.S.A. 102 8 (2005) 2832-2837
44. Sayah D.M., Sokolskaja E., Berthoux L., and Luban J. Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1. Nature 430 (2004) 569-573
45. Shibata R., Sakai H., Kawamura M., Tokunaga K., and Adachi A. Early replication block of human immunodeficiency virus type 1 in monkey cells. J. Gen. Virol. 76 Pt. 11 (1995) 2723-2730
46. Si Z., Vandegraaff N., O'Huigin C., Song B., Yuan W., Xu C., Perron M., Li X., Marasco W.A., Engelman A., Dean M., and Sodroski J. Evolution of a cytoplasmic tripartite motif (TRIM) protein in cows that restricts retroviral infection. Proc. Natl. Acad. Sci. U.S.A. 103 19 (2006) 7454-7459
47. Song B., Diaz-Griffero F., Park D.H., Rogers T., Stremlau M., and Sodroski J. TRIM5alpha association with cytoplasmic bodies is not required for antiretroviral activity. Virology 343 2 (2005) 201-211
48. Song B., Gold B., O'hUigin C., Javanbakht H., Li X., Stremlau M., Winkler C., Dean M., and Sodroski J. The B30.2(SPRY) domain of the retroviral restriction factor TRIM5α exhibits lineage-specific length and sequence variation in primates. J. Virol. 79 (2005) 6111-6121
49. Song B., Javanbakht H., Perron M., Park D.H., Stremlau M., and Sodroski J. Retrovirus restriction by TRIM5alpha variants from Old World and New World primates. J. Virol. 79 7 (2005) 3930-3937
50. Stoye J.P. An intracellular block to primate lentivirus replication. Proc. Natl. Acad. Sci. U.S.A. 99 18 (2002) 11549-11551
51. Stremlau M., Owens C.M., Perron M.J., Kiessling M., Autissier P., and Sodroski J. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 427 6977 (2004) 848-853
52. Stremlau M., Perron M., Lee M., Li Y., Song B., Javanbakht H., Diaz-Griffero F., Anderson D.J., Sundquist W.I., and Sodroski J. Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor. Proc. Natl. Acad. Sci. U.S.A. 103 14 (2006) 5514-5519
53. Swofford D.L. PAUP*. Phylogenetic Analysis Using Parsimony (* and Other Methods) (2002), Sinauer Associates, Sunderland, MA Version 4
54. Tavalai N., Papior P., Rechter S., Leis M., and Stamminger T. Evidence for a role of the cellular ND10 protein PML in mediating intrinsic immunity against human cytomegalovirus infections. J. Virol. 80 (2006) 8006-8018
55. Tissot C., and Mechti N. Molecular cloning of a new interferon-induced factor that represses human immunodeficiency virus type 1 long terminal repeat expression. J. Biol. Chem. 270 25 (1995) 14891-14898
56. Towers G., Bock M., Martin S., Takeuchi Y., Stoye J.P., and Danos O. A conserved mechanism of retrovirus restriction in mammals. Proc. Natl. Acad. Sci. U.S.A. 97 22 (2000) 12295-12299
57. Yap M.W., Nisole S., Lynch C., and Stoye J.P. Trim5alpha protein restricts both HIV-1 and murine leukemia virus. Proc. Natl. Acad. Sci. U.S.A. 101 29 (2004) 10786-10791
58. Yap M.W., Dodding M.P., and Stoye J.P. Trim-cyclophilin A fusion proteins can restrict human immunodeficiency virus type 1 infection at two distinct phases in the viral life cycle. J. Virol. 80 8 (2006) 4061-4067
59. Yee J.K., Friedmann T., and Burns J.C. Generation of high-titer pseudotyped retroviral vectors with very broad host range. Methods Cell Biol. 43 Pt. A (1994) 99-112
60. Ylinen L.M., Keckesova Z., Webb B.L., Gifford R.J., Smith T.P., and Towers G.J. Isolation of an active Lv1 gene from cattle indicates that tripartite motif protein-mediated innate immunity to retroviral infection is widespread among mammals. J. Virol. 80 15 (2006) 7332-7338
61. Zhang F., Hatziioannou T., Perez-Caballero D., Derse D., and Bieniasz P.D. Antiretroviral potential of human tripartite motif-5 and related proteins. Virology 353 2 (2006) 396-409